Gangliosides as Immunomodulators
Gangliosides are glycosphingolipids expressed at the outer leaflet of the plasmatic membrane of cells from vertebrate organisms. These molecules exert diverse biological functions including modulation of the immune system responses. Aberrant expression of gangliosides has been demonstrated on malignant cells. Besides expression on tumor cell membranes, gangliosides are also shed in the tumor microenvironment and eventually circulate in patients blood. Gangliosides derived from tumors posses the capability to affect the immune system responses by altering the function of lymphocytes and antigen-presenting cells and promoting tumor growth. These molecules can be considered as tumor weapons directed to attack and destroy immunosurveillance mechanisms devoted to control cancer progression.
KeywordsSialic Acid Neuraminic Acid Immune System Response GD1a Ganglioside Ganglioside Biosynthesis
Unable to display preview. Download preview PDF.
- Bergelson, L.D. (1995) Serum gangliosides as endogenous immunomodulators. Immunol. Today 16, 483–486.Google Scholar
- Boon, T., Coulie, P.G. and Van den Eynde, B. (1997) Tumor antigens recognized by T cells. Immunol. Today 18, 267–268.Google Scholar
- Diatlovitskaia, E.V., Kliuchareva, E.V., Matveeva, V.A., Sinitsyna, E.V. and Akhmed-Zade, A.S. (1985) Effect of gangliosides on the cytotoxic activity of natural killers from Syrian hamsters. Biochemistry (Russia) 50, 1514–1516.Google Scholar
- Finke, J.H., Rayman, P., George, R., Tannenbaum, C.S., Kolenko, V., Uzzo, R., Novick, A.C. and Bukowski, R.M. (2001) Tumor-induced sensitivity to apoptosis in T cells from patients with renal cell carcinoma: role of nuclear factor-kappaB suppression. Clin. Cancer Res. 7, 940s–946s.PubMedGoogle Scholar
- Klenk (1941) Uber die ganglioside, eine neue gruppe von zukerhaltigen gehirnlipoiden. Z. Physiol. Chem. 273, 76.Google Scholar
- Klenk (1942) Neuraminsaure, das spaltprodukt eines neuen gehirnlipoids. Z. Physiol. Chem. 268, 50.Google Scholar
- Ladisch, S., Becker, H. and Ulsh, L. (1992) Immunosuppression by human gangliosides: I. Relationship of carbohydrate structure to the inhibition of T cell responses. Biochimica et Biophysica Acta 1125, 180–188.Google Scholar
- Somova, O.G., Tekieva, E.A., Diatlovitskaia, E.V., Bassalyk, L.S. and Bergel’son, L.D. (1991) Ganglioside (GD3) in serum of cancer patients. Vopr. Med. Khim. (Russia) 37, 21–23.Google Scholar
- Thornton, M.V., Kudo, D., Rayman, P., Horton, C., Molto, L., Cathcart, M.K., Ng, C., Paszkiewicz-Kozik, E., Bukowski, R., Derweesh, I., Tannenbaum, C.S. and Finke, J.H. (2004) Degradation of NF-kappa B in T cells by gangliosides expressed on renal cell carcinomas. J. Immunol. 172, 3480–3490.PubMedGoogle Scholar